In this study, we applied quantitative reverse transcription‐PCR (qRT‐PCR) assay to assess the expression of lncRNA MALAT1 and miR‐101 in TMZ‐resistant GBM cell lines and the parental cell lines. This evidence concerns the gene MALAT1 and glioblastoma.